{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:29:18Z","timestamp":1790314158803,"version":"4.1.0"},"reference-count":38,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2023,1,2]]},"DOI":"10.1080\/10428194.2022.2136956","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T12:14:37Z","timestamp":1668773677000},"page":"130-139","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":27,"title":["Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study"],"prefix":"10.1080","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6117-320X","authenticated-orcid":false,"given":"John","family":"Kuruvilla","sequence":"first","affiliation":[{"name":"Princess Margaret Cancer Centre, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Armand","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Hamadani","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin, Milwaukee, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Kline","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Chicago, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig H.","family":"Moskowitz","sequence":"additional","affiliation":[{"name":"Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Avigan","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0850-6730","authenticated-orcid":false,"given":"Joshua D.","family":"Brody","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Ribrag","sequence":"additional","affiliation":[{"name":"Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex F.","family":"Herrera","sequence":"additional","affiliation":[{"name":"City of Hope, Duarte, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3714-9824","authenticated-orcid":false,"given":"Franck","family":"Morschhauser","sequence":"additional","affiliation":[{"name":"Department of Hematology, CHU Lille, Lille University, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Kanate","sequence":"additional","affiliation":[{"name":"HonorHealth Cancer Transplant Institute, Scottsdale, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Zinzani","sequence":"additional","affiliation":[{"name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia \u201cSer\u00e0gnoli\u201d, Bologna, Italy"},{"name":"Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Universit\u00e0 di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Bitran","sequence":"additional","affiliation":[{"name":"Advocate Lutheran General Hospital, Park Ridge, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3131-3718","authenticated-orcid":false,"given":"Herve","family":"Ghesquieres","sequence":"additional","affiliation":[{"name":"Lyon-Sud Hospital Center, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Schuster","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Farooqui","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc., Rahway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Marinello","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc., Rahway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-394X","authenticated-orcid":false,"given":"Nancy L.","family":"Bartlett","sequence":"additional","affiliation":[{"name":"Siteman Cancer Center, Washington University, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"key":"CIT0001","unstructured":"American Cancer Society. Types of B-cell lymphoma. Atlanta (GA): American Cancer Society; 2019 [updated 2019 Jan 29; cited 2021 Mar 15]. Available from: https:\/\/www.cancer.org\/cancer\/non-hodgkin-lymphoma\/about\/b-cell-lymphoma.html"},{"key":"CIT0002","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines for Clinical Oncology. Small cell lung cancer. Version 2.2021. Plymouth Meeting (PA): National Comprehensive Cancer Network; 2021 [updated 2021 Jan 11; cited 2021 Jan 25]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/sclc.pdf"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-769620"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15708"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30864-7"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001843"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0892-7"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01389"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-010-0909-y"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-421826"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-216671"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-282780"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.3467"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001367"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000215"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15888"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2437_49"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.3429"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq626"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2011.02.001"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.95"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-1471"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30225-4"},{"key":"CIT0025","volume-title":"Common Terminology Criteria for Adverse Events (CTCAE) version 4.0","author":"US Department of Health and Human Services","year":"2009"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2007.06.011"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1177\/1740774507079442"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000324"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30109-7"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30110-3"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.9789"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00766"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004753"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007683"},{"key":"CIT0035","unstructured":"LymphomaHub. Primary analysis of phase I\/II of the ZUMA-6 trial \u2013 axicabtagene ciloleucel plus atezolizumab for patients with refractory DLBCL LymphomaHub website: LymphomaHub; 2020 [updated 2020 Jun 5; cited 2021 2021 May 4]."},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-123368"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-124102"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15946"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2022.2136956","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T03:23:55Z","timestamp":1680405835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2022.2136956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,2]]}},"alternative-id":["10.1080\/10428194.2022.2136956"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2022.2136956","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-07-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}